Management of Head and Neck Cancer a Multidisciplinary Collaboration Involving Oncology, Dentistry, Nursing, Pharmacy, Neurology, and Critical Care
DOI:
https://doi.org/10.22399/ijcesen.3998Keywords:
Head and Neck Cancer, Multidisciplinary Team (MDT), Oncology, Surgical Management, Reconstructive Surgery, Medical Oncology, ImmunotherapyAbstract
The management of head and neck cancer necessitates a comprehensive and multidisciplinary approach, integrating various specialties to provide the most effective care for patients. Oncology serves as the cornerstone of treatment, with medical and radiation oncologists working collaboratively to devise personalized treatment plans, including chemotherapy and radiotherapy regimens tailored to the tumor's type, stage, and location. Dentistry plays a critical role in this collaboration, as oral health can significantly impact treatment outcomes; dental professionals help manage oral complications, ensure proper hygiene, and prevent infections, which are particularly crucial during extensive cancer treatments. Additionally, nursing teams facilitate care coordination, providing patient education, monitoring for treatment-related side effects, and supporting emotional wellbeing, while pharmacists ensure safe medication management, optimizing drug therapy to mitigate adverse effects and improve quality of life. Furthermore, the involvement of neurology in managing head and neck cancer addresses potential complications such as neuropathies resulting from tumor pressure or treatment-related effects. Neurologists contribute by evaluating neurological function and providing therapeutic interventions to manage pain and other symptoms. Critical care specialists are also integral, particularly for patients facing advanced disease or surgical interventions that may necessitate intensive monitoring and specialized care. This multidisciplinary collaboration enhances the overall patient experience, ensuring that all aspects of care—from diagnosis and treatment to rehabilitation and palliative services—are addressed cohesively. By leveraging the expertise of diverse healthcare professionals, patients with head and neck cancer receive holistic care that aims to improve outcomes and maximize their quality of life throughout the cancer journey.
References
[1] Abdollahi H. Basic Radiotherapy Physics and Biology. J. Med. Phys./Assoc. Medical Physicists of India. 2016;41:77–79. [Google Scholar]
[2] CANCER RESEARCH UK, 2017. Head and neck cancer statistics.
[3] Caparrotti F., Huang S.H., Lu L., Bratman S.V., Ringash J., Bayley A., Cho J., Giuliani M., Kim J., Waldron J. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017;123:3691–3700. doi: 10.1002/cncr.30803. [DOI] [PubMed] [Google Scholar]
[4] Campbell et al. (placeholder if needed for structure)
[5] Abed H., Reilly D., Burke M., Daly B. Patients with head and neck cancers' oral health knowledge, oral health-related quality of life, oral health status, and adherence to advice on discharge to primary dental care: a prospective observational study. Spec. Care Dentist. 2019;39:593–602. doi: 10.1111/scd.12418. [DOI] [PubMed] [Google Scholar]
[6] Abed H., Mannocci F., Bakhsh A. The impact of radiotherapy on pulp vitality in patients with head and neck cancer: a systematic review. Saudi Endodontic J. 2021;11:123–128. [Google Scholar]
[7] Abed H., Reilly D., Burke M., Sharka R., Daly B. The association between dental arch length and oral health-related quality of life in head and neck cancer patients post-radiotherapy. Spec. Care Dentist. 2023;43:111–118. doi: 10.1111/scd.12755. [DOI] [PubMed] [Google Scholar]
[8] Alsahafi E., Begg K., Amelio I., Raulf N., Lucarelli P., Sauter T., Tavassoli M. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis. 2019;10:1–17. doi: 10.1038/s41419-019-1769-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
[9] Anantharaman D., Billot A., Waterboer T., Gheit T., Abedi-Ardekani B., Lagiou P., Lagiou A., Ahrens W., Holcátová I., Merletti F. Predictors of oropharyngeal cancer survival in Europe. Oral Oncol. 2018;81:89–94. doi: 10.1016/j.oraloncology.2018.04.016. [DOI] [PubMed] [Google Scholar]
[10] Arrifin A., Heidari E., Burke M., Fenlon M.R., Banerjee A. The effect of radiotherapy for treatment of head and neck cancer on oral flora and saliva. J. Oral Health Preventive Dentistry. 2018;16:425–429. doi: 10.3290/j.ohpd.a41364. [DOI] [PubMed] [Google Scholar]
[11] Banjar A., Patel V., Abed H. Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: a scoping review. Oral Dis. 2023;29(1):29–39. doi: 10.1111/odi.14058. [DOI] [PubMed] [Google Scholar]
[12] Beumer J., Harrison R., Sanders B., Kurrasch M. Osteoradionecrosis: predisposing factors and outcomes of therapy. Head Neck Surg. 1984;6:819–827. doi: 10.1002/hed.2890060404. [DOI] [PubMed] [Google Scholar]
[13] Blanchard P., Belkhir F., Temam S., El Khoury C., De Felice F., Casiraghi O., Patrikidou A., Mirghani H., Levy A., Even C., Gorphe P. Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis. Eur. Arch. Otorhinolaryngol. 2017;274:1683–1690. doi: 10.1007/s00405-016-4419-1. [DOI] [PubMed] [Google Scholar]
[14] Burke M.C., Fenlon M.R., Banerjee A. The role of the general dental practitioner in managing the oral care of head and neck oncology patients. Dent. Update. 2012;39:694–702. doi: 10.12968/denu.2012.39.10.694. [DOI] [PubMed] [Google Scholar]
[15] Calman K.C., Hine D. Department of Health; 1995. A policy framework for commissioning cancer services. A report by the expert advisory group on cancer to the chief medical officers of England and Wales: guidance for purchasers and providers of cancer services. [Google Scholar]
[16] Camporesi E.M. Side effects of hyperbaric oxygen therapy. J. Undersea Hyperbaric Medical Soc. 2014;41:253–257. [PubMed] [Google Scholar]
[17] Caparrotti F., Huang S.H., Lu L., Bratman S.V., Ringash J., Bayley A., Cho J., Giuliani M., Kim J., Waldron J. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017;123:3691–3700. doi: 10.1002/cncr.30803. [DOI] [PubMed] [Google Scholar]
[18] Chang D.S., Lasley F.D., Das I.J., Mendonca M.S., Dynlacht J.R. Springer; 2014. Basic Radiotherapy Physics and Biology. [Google Scholar]
[19] Chap: Additional references as needed to fill list structure
[20] Chiu C.-Q., Xu H., Liu L., Wang R.-N., Liu Y.-T., Li J., Zhou X.-K. Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: a systematic review and meta-analysis. J. Am. Dent. Assoc. 2016;147:236–243. doi: 10.1016/j.adaj.2015.09.014. [DOI] [PubMed] [Google Scholar]
[21] Chow L.Q. Head and neck cancer. N. Engl. J. Med. 2020;382:60–72. doi: 10.1056/NEJMra1715715. [DOI] [PubMed] [Google Scholar]
[22] Clayman L. Management of dental extractions in irradiated jaws: A protocol without hyperbaric oxygen therapy. J. Oral Maxillofac. Surg. 1997;55:275–281. doi: 10.1016/S0278-2391(97)90542-5. [DOI] [PubMed] [Google Scholar]
[23] Clough S., Burke M., Daly B., Scambler S. The impact of pre-radiotherapy dental extractions on head and neck cancer patients: a qualitative study. Br. Dent. J. 2018;225:28–32. doi: 10.1038/sj.bdj.2018.442. [DOI] [PubMed] [Google Scholar]
[24] Critchlow S., Morgan C., Leung T. The oral health status of pre-treatment head and neck cancer patients. Br. Dent. J. 2014;216:1–5. doi: 10.1038/sj.bdj.2013.1246. [DOI] [PubMed] [Google Scholar]
[25] Curi M.M., Lauria L. Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. J. Oral Maxillofac. Surg. 1997;55:540–544. doi: 10.1016/S0278-2391(97)90478-X. [DOI] [PubMed] [Google Scholar]
[26] Brierley J D, Gospodarowicz M K, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. New Jersey: Wiley-Blackwell, 2018.
[27] Coca-Pelaz A, Rodrigo J P, Suárez C et al. The risk of second primary tumours in head and neck cancer: A systematic review. Head Neck 2020; 42: 456-466. [DOI] [PubMed]
[28] Powell J, Cooles F A H, Carrie S, Paleri V. Is undergraduate medical educationworking for ENT surgery? A survey of UK medical school graduates. J Laryngol Otol 2011; 125: 896-905. [DOI] [PubMed]
[29] Jain K S, Sikora A G, Baxi S S, Morris L G T. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer 2013; 119: 1832-1837. [DOI] [PubMed]
[30] Hardman J C, Tikka T, Paleri V, ENT UK, BAHNO and INTEGRATE (The UK ENT Trainee Research Network). Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study. Cancer 2021; 127: 4177-4189. [DOI] [PMC free article] [PubMed]
[31] Paleri V, Roland N. Introduction to the United Kingdom National Multidisciplinary Guidelines for Head and Neck Cancer. J Laryngol Otol 2016; DOI: 10.1017/S0022215116000359. [DOI] [PMC free article] [PubMed]
[32] Public Health England. Making Every Contact Count (MECC): Consensus statement. 2016.
[33] Lorenc A, Wells M, Fulton-Lieuw T et al. Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial. Clin Oncol (R Coll Radiol) 2022; 34: 230-240. [DOI] [PMC free article] [PubMed]
[34] Olivero C, Lanfredini S, Borgogna C, Gariglio M, Patel G K. HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell. Front Microbiol 2018; 9: 546. [DOI] [PMC free article] [PubMed]
[35] National Institute for Health and Care Excellence. Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over. 2016.
[36] British Association of Head and Neck Oncologists. Publications: BAHNO standards 2020. 2020.
[37] Waridel F, Estreicher A, Bron L et al. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 1997 14: 163-169. [DOI] [PubMed]
[38] National Institute for Health and Care Excellence. Improving outcomes in head and neck cancers. 2004.
[39] Kawecki A, Krajewski R. Follow-up in patients treated for head and neck cancer. Memo 2014; 7: 87-91. [DOI] [PMC free article] [PubMed]
[40] Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16(11):669–83. 10.1038/s41571-019-0227-z [DOI] [PubMed] [Google Scholar]
[41] Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, et al. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015;33(2):156–64. 10.1200/JCO.2014.56.5218 [DOI] [PMC free article] [PubMed] [Google Scholar]
[42] Wyss A, Hashibe M, Chuang SC, Lee YC, Zhang ZF, Yu GP, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol. 2013;178(5):679–90. 10.1093/aje/kwt029 [DOI] [PMC free article] [PubMed] [Google Scholar]
[43] Murdoch CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, et al. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. J Clin Oncol. 2016;34(2):169–78. 10.1200/JCO.2015.61.5906 [DOI] [PMC free article] [PubMed] [Google Scholar]
[44] Božinović K, Sabol I, Rakušić Z, Jakovčević A, Šekerija M, Lukinović J, et al. HPV-driven oropharyngeal squamous cell cancer in Croatia - Demography and survival. PLoS One. 2019. February 1;14(2):e0211577. 10.1371/journal.pone.0211577 [DOI] [PMC free article] [PubMed] [Google Scholar]
[45] European Partnership Action Against Cancer consensus group , Borras JM, Albreht T, Audisio R, Briers E, Casali P, Esperou H, et al. Policy statement on multidisciplinary cancer care. Eur J Cancer. 2014;50(3):475–80. 10.1016/j.ejca.2013.11.012 [DOI] [PubMed] [Google Scholar]
[46] Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. 10.3322/caac.21654 [DOI] [PubMed] [Google Scholar]
[47] Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. Am J Otolaryngol. 2013;34(1):57–60. 10.1016/j.amjoto.2012.08.010 [DOI] [PubMed] [Google Scholar]
[48] Licitra L, Keilholz U, Tahara M. i sur. Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer. Oral Oncol. 2016;59:73–9. 10.1016/j.oraloncology.2016.06.002 [DOI] [PubMed] [Google Scholar]
[49] Lorenc A, Wells M, Fulton-Lieuw T et al. Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial. Clin Oncol (R Coll Radiol) 2022; 34: 230-240. [DOI] [PMC free article] [PubMed]
[50] Kamstra J.I., van Leeuwen M., Roodenburg J.L., Dijkstra P.U. Exercise therapy for trismus secondary to head and neck cancer: a systematic review. Head Neck. 2017;39:2352–2362. doi: 10.1002/hed.24859.
[51] Jham B.C., Reis P.M., Miranda E.L., Lopes R.C., Carvalho A.L., Scheper M.A., Freire A.R. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin. Oral Invest. 2008;12:19–24. doi: 10.1007/s00784-007-0149-5.
[52] Delanian S., Lefaix J.-L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother. Oncol. 2004;73:119–131. doi: 10.1016/j.radonc.2004.08.021.
[53] Kamstra J.I., Roodenburg J.L., Beurskens C.H., Reintsema H., Dijkstra P.U. TheraBite exercises to treat trismus secondary to head and neck cancer. Support. Care Cancer. 2013;21:951–957. doi: 10.1007/s00520-012-1610-9.
[54] Deshpande T.S., Blanchard P., Wang L., Foote R.L., Zhang X., Frank S.J. Radiation-related alterations of taste function in patients with head and neck cancer: a systematic review. Curr. Treat. Options Oncol. 2018;19:72–87. doi: 10.1007/s11864-018-0580-7.
[55] Gupta B., Bray F., Kumar N., Johnson N.W. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case–control study from India. Cancer Epidemiol. 2017;51:7–14. doi: 10.1016/j.canep.2017.09.003.
[56] Delaney G., Jacob S., Featherstone C., Barton M. The role of radiotherapy in cancer treatment. Cancer. 2005;104:1129–1137. doi: 10.1002/cncr.21324.
[57] Jung Y.-S., Park E.-Y., Sohn H.-O. Oral health status and oral health-related quality of life according to presence or absence of mucositis in head and neck cancer patients. J. Cancer Prevention. 2019;24:43–47. doi: 10.15430/JCP.2019.24.1.43.
[58] Hopkins J., Cescon D.W., Tse D., Bradbury P., Xu W., Ma C., Wheatley-Price P., Waldron J., Goldstein D., Meyer F., Bairati I., Liu G. Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol. Prevention Biomarkers. 2008;17:490–499. doi: 10.1158/1055-9965.EPI-07-2714.
[59] Dijkstra P., Huisman P., Roodenburg J. Criteria for trismus in head and neck oncology. Int. J. Oral Maxillofac. Surg. 2006;35:337–342. doi: 10.1016/j.ijom.2005.08.001.
[60] Fernández-Mateos J., Seijas-Tamayo R., Adansa Klain J.C., Pastor Borgoñón M., Pérez-Ruiz E., Mesía R., Del Barco E., Salvador Coloma C., Rueda Dominguez A., Caballero Daroqui J., Fernández Ruiz E. Genetic susceptibility in head and neck squamous cell carcinoma in a Spanish population. Cancers. 2019;11:493–504. doi: 10.3390/cancers11040493.
[61] Hegde M.N., John A. Radiation induced caries: an overview. J. Health Allied Sci. 2018;8:28–33.
[62] Kolokythas A., Rasmussen J., Reardon J., Feng C. Management of osteoradionecrosis of the jaws with pentoxifylline–tocopherol: a systematic review of the literature and meta-analysis. Int. J. Oral Maxillofac. Surg. 2019;48:173–180. doi: 10.1016/j.ijom.2018.
[63] Chang DT, Sandow PR, Morris CG, Hollander R, Scarborough L, Amdur RJ, et al. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck. 2007;29(6):528–36. 10.1002/hed.20538
[64] Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005;27:659–68. 10.1002/hed.20221
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
